Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia

Fertility and Sterility
C WangK K Yeung

Abstract

Forty-six subfertile men with idiopathic oligospermia were randomly assigned to 6 months of treatment with a placebo, clomiphene citrate (25 or 50 mg/day), mesterolone (100 mg/day), or pentoxifylline (1200 mg/day) or 4 months of testosterone enanthate treatment (100 or 250 mg on alternate weeks). Treatment with the placebo, mesterolone, pentoxifylline, and testosterone rebound therapy did not result in a significant increase in the mean sperm concentration or pregnancy in the partners. Clomiphene citrate at both dosages significantly increased the mean sperm concentration without improving sperm motility or morphology during the 6-month treatment period. Pregnancy rates of 36.4% and 22.2% were observed in partners of men receiving clomiphene citrate 25 mg/day and 50 mg/day, respectively. This study also illustrates the difficulties in identifying suitable patients for and assessing the efficacy of different treatment regimens.

Citations

Feb 1, 1993·Clinical Endocrinology·E Nieschlag
Jul 20, 2007·The Cochrane Database of Systematic Reviews·P VandekerckhoveE Hughes
Oct 14, 2014·Clinical and Experimental Reproductive Medicine·Jae Hung Jung, Ju Tae Seo
Apr 20, 2016·Nature Reviews. Urology·Martin Kathrins, Craig Niederberger
Jun 1, 1991·British Journal of Clinical Pharmacology·M R ShenS S Chen
Feb 1, 1988·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·T R Varma, R H Patel
Aug 1, 1992·Annals of Medicine·K Purvis, E Christiansen
Jan 1, 1996·Obstetrical & Gynecological Survey·V L Baker, R B Jaffe
Jan 6, 2011·Der Urologe. Ausg. A·M TrottmannA J Becker
Dec 4, 2012·Reproductive Sciences·Amy E WilletsJamie N Brown
Jul 1, 1996·International Journal of Urology : Official Journal of the Japanese Urological Association·M Namiki
Jul 1, 1994·Archives of Andrology·U MaierG Ludvik
Nov 6, 2012·Expert Opinion on Pharmacotherapy·Alaa J HamadaAshok Agarwal
Dec 17, 2014·The Cochrane Database of Systematic Reviews·Marian G ShowellRoger J Hart
Mar 14, 2019·The Cochrane Database of Systematic Reviews·Roos M SmitsMarian G Showell
Nov 1, 1993·British Journal of Obstetrics and Gynaecology·P VandekerckhoveT W Harada
Dec 19, 2007·Asian Journal of Andrology·F DimitriadisN Sofikitis
Jan 19, 2011·Nature Reviews. Urology·Kathleen HwangLarry I Lipshultz
Jan 1, 1997·World Journal of Urology·E D Kim, L I Lipshultz
Feb 2, 1995·The New England Journal of Medicine·S S Howards
Jul 1, 1997·Archives of Andrology·G MerinoS Carranza-Lira
Jul 1, 1993·Archives of Andrology·H FuseT Katayama
Jul 20, 2007·The Cochrane Database of Systematic Reviews·P VandekerckhoveE Hughes
Jan 24, 2021·Endocrine Reviews·David J Handelsman
Jan 9, 2003·The Urologic Clinics of North America·Farjaad M Siddiq, Mark Sigman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.